Theravia

Theravia company information, Employees & Contact Information

Explore related pages

Related company profiles:

theravia is a leading international pharmaceutical company focused on rare and neglected diseases. Established through the merger of Addmedica and CTRS, we are committed to tackling the unmet medical needs of patients facing these difficult conditions. For more information, please visit our website: https://theravia.com

Company Details

Employees
40
Founded
-
Address
16 Rue Montrosier, Neuilly - Sur - Seine,ile De France 92200,france
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Keywords
Manager jobs.
HQ
Neuilly - sur - Seine, Ile de France
Looking for a particular Theravia employee's phone or email?

Theravia Questions

News

Norgine completes acquisition of Theravia - PR Newswire

Norgine completes acquisition of Theravia PR Newswire

Tampere University licenses to Theravia a drug molecule intended for rare and severe skin disorders - EurekAlert!

Tampere University licenses to Theravia a drug molecule intended for rare and severe skin disorders EurekAlert!

Norgine on a growth charge again with Theravia takeover deal - pharmaphorum

Norgine on a growth charge again with Theravia takeover deal pharmaphorum

Norgine strengthens rare disease portfolio with acquisition of Theravia - PR Newswire

Norgine strengthens rare disease portfolio with acquisition of Theravia PR Newswire

Tampere University licenses to Theravia a drug molecule intended for rare and severe skin disorders - Tampereen korkeakouluyhteisö

Tampere University licenses to Theravia a drug molecule intended for rare and severe skin disorders Tampereen korkeakouluyhteisö

Latham Advises Norgine on Acquisition of Theravia - Latham & Watkins LLP

Latham Advises Norgine on Acquisition of Theravia Latham & Watkins LLP

Theravia licenses DCN-tCRK molecule as potential EB treatment - Epidermolysis Bullosa News

Theravia licenses DCN-tCRK molecule as potential EB treatment Epidermolysis Bullosa News

Mérieux Equity Partners to sell Theravia to Norgine - pehub.com

Mérieux Equity Partners to sell Theravia to Norgine pehub.com

France: Mérieux Equity Partners sells stake in Theravia to Norgine - Investors in Healthcare

France: Mérieux Equity Partners sells stake in Theravia to Norgine Investors in Healthcare

Abacus Medicine Pharma Services and AddMedica sign partnership agreement for the distribution of Siklos® in Benelux - Pharmaceutical Technology

Abacus Medicine Pharma Services and AddMedica sign partnership agreement for the distribution of Siklos® in Benelux Pharmaceutical Technology

Top Theravia Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant